Clinical Trial Update: Tolerance and Efficacy of Rituximab in Sjogren's Disease [Phase 2, Phase 3]

View source ↗

Summary

An update on phase 2/phase 3 trials evaluating Rituximab for Sjögren's syndrome, focusing on tolerability and efficacy. The phase 2/phase 3 program has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: University Hospital, Brest | Conditions: Sjogren's Disease | Phase 2, Phase 3 | Status: COMPLETED